Category: insurance
-
U.S. court strikes down Florida transgender health rule
A U.S. judge on Wednesday struck down a Florida rule and a statute that banned state Medicaid payments for transgender healthcare, marking the second defeat in two weeks for anti-transgender legislation in the state. Rating: Transneutral, Reuters, June 22, 2023 (PDF archive) (HTML archive)
-
Federal judge blocks Florida ban on Medicaid funds for transgender treatment
A federal judge on Wednesday struck down Florida rules championed by Gov. Ron DeSantis restricting Medicaid coverage for gender dysphoria treatments for potentially thousands of transgender people. Rating: Transneutral, CBS, June 22, 2023 (PDF archive) (HTML archive) (Video archive)
-
Ron DeSantis loses again in court on anti-transgender health law
A federal judge on Wednesday struck down regulations in Florida that banned government healthcare programs from paying for treatments like puberty-blocking medication and hormone therapy for transgender people. Rating: Transneutral, Business Insider, June 21, 2023 (PDF archive) (HTML archive) (Legal document)
-
Transgender care bans cause families to flee to other states
‘I’ve kept her safe’: Families flee states with transgender care bans to protect their children Rating: Transsupportive, USA Today, June 20, 2023, PDF archive, HTML archive
-
National Health Service (NHS): Gender Villain
The National Health Service in England is planning to no longer offer puberty blockers to children, except for limited research purposes.
-
Elon Musk Celebrates Pride Month By Going On An Anti-Trans Tweeting Spree
Critics say the platform isn’t safe for trans users after the company rolled back protections against “targeted misgendering.” Rating: Transsupportive, Huffington Post, June 12, 2023 (PDF archive) (Video archive)
-
Britain Limits Use of Puberty-Blocking Drugs to Research Only
Britain’s National Health Service announced on Friday that it would limit the use of puberty-suppressing drugs to children enrolled in clinical trials. The change comes as the agency’s pediatric gender services have struggled to keep up with soaring demand. Rating: Transneutral, New York Times, June 9, 2023 (PDF archive)
-
NHS will not offer puberty blockers to children suffering from gender dysphoria
Guidance ‘will go down in safeguarding history’ as hormone-suppressing drugs will not be routinely recommended at two new clinics in England. Rating: Transphobic, Telegraph, June 9, 2023 (PDF archive)
-
Puberty blockers will not be routinely offered to children at new gender clinics
Puberty-supressing hormones will generally only be commissioned as part of clinical research, NHS England said. Rating: Transneutral, Independent, June 9, 2023 (PDF archive)